Evaxion Biotech AS (EVAX)
1.60
-0.08
(-4.76%)
USD |
NASDAQ |
Nov 15, 09:42
Evaxion Biotech Total Return Level: 1.68 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 1.68 |
November 13, 2024 | 1.76 |
November 12, 2024 | 2.38 |
November 11, 2024 | 2.42 |
November 08, 2024 | 2.50 |
November 07, 2024 | 2.62 |
November 06, 2024 | 2.57 |
November 05, 2024 | 2.61 |
November 04, 2024 | 2.64 |
November 01, 2024 | 2.59 |
October 31, 2024 | 2.67 |
October 30, 2024 | 2.76 |
October 29, 2024 | 2.91 |
October 28, 2024 | 2.84 |
October 25, 2024 | 2.76 |
October 24, 2024 | 2.65 |
October 23, 2024 | 2.67 |
October 22, 2024 | 2.56 |
October 21, 2024 | 2.54 |
October 18, 2024 | 2.64 |
October 17, 2024 | 2.71 |
October 16, 2024 | 2.71 |
October 15, 2024 | 2.60 |
October 14, 2024 | 2.69 |
October 11, 2024 | 2.60 |
Date | Value |
---|---|
October 10, 2024 | 2.63 |
October 09, 2024 | 2.68 |
October 08, 2024 | 2.84 |
October 07, 2024 | 2.85 |
October 04, 2024 | 2.95 |
October 03, 2024 | 3.06 |
October 02, 2024 | 2.98 |
October 01, 2024 | 2.93 |
September 30, 2024 | 3.11 |
September 27, 2024 | 3.12 |
September 26, 2024 | 3.06 |
September 25, 2024 | 2.83 |
September 24, 2024 | 2.97 |
September 23, 2024 | 2.95 |
September 20, 2024 | 2.99 |
September 19, 2024 | 3.15 |
September 18, 2024 | 3.12 |
September 17, 2024 | 3.03 |
September 16, 2024 | 3.25 |
September 13, 2024 | 3.00 |
September 12, 2024 | 3.06 |
September 11, 2024 | 3.14 |
September 10, 2024 | 3.20 |
September 09, 2024 | 3.25 |
September 06, 2024 | 3.45 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.68
Minimum
Nov 14 2024
126.80
Maximum
Nov 04 2021
27.05
Average
17.40
Median
May 13 2022
Total Return Level Benchmarks
Ascendis Pharma AS | 124.28 |
Adaptimmune Therapeutics PLC | 0.5912 |
Akari Therapeutics PLC | 2.23 |
Biodexa Pharmaceuticals PLC | 4.86 |
Verona Pharma PLC | 35.37 |